Mark Steven Duxon
Fondateur chez Transpharmation Ltd.
Postes actifs de Mark Steven Duxon
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Transpharmation Ltd.
 Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Directeur/Membre du Conseil | 23/01/2012 | - |
| Directeur Général | 17/08/2010 | - | |
| Fondateur | 17/08/2010 | - | |
Vivocore, Inc.
 Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Mark Steven Duxon
Statistiques
Internationale
| Royaume-Uni | 2 |
| Canada | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
- Bourse
- Insiders
- Mark Steven Duxon
- Expérience
